rss
Br J Ophthalmol 82:561-568 doi:10.1136/bjo.82.5.561
  • Original Article
    • Laboratory science

VEGF localisation in diabetic retinopathy

Table 2

Mean (SD) intensity of immunostaining of the retina/choroid using an anti-VEGF121,165,189antibody

Tissue layer
Tissue category Choroidal vessels RPE Outer retina Inner retina Retinal vessels Ganglion cell layer ILM
Normal (n=12) 0.3 (0.1) 0.5 (0.4) 0.2 (0.1) 0.2 (0.1) 0.3 (0.1) 0.4 (0.2) 0.3 (0.2)
Diabetic:
No overt retinopathy (n=19) 0.7 (0.2) 1.3 (0.2) 0.8 (0.2) 1.6 (0.2) 1.0 (0.2) 1.9 (0.2) 1.5 (0.2)
 Vascular abnormalities (n=6) 0.5 (0.3) 0.8 (0.4) 0.3 (0.3) 1.2 (0.5) 1.1 (0.4) 1.7 (0.4) 1.3 (0.4)
 PDR (n=6) 1.0 (0.5) 1.8 (0.4) 1.5 (0.4) 1.8 (0.3) 2.2 (0.3) 2.0 (0.4) 1.8 (0.4)
 Laser, no PDR (n=15) 0.7 (0.2) 1.2 (0.3) 1.2 (0.3) 1.1 (0.2) 1.0 (0.2) 1.2 (0.2) 1.0 (0.2)
  • 0 = background, 1 = weak, 2 = moderate, 3 = intense.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.